Literature DB >> 9378379

Atropine inhibits gastric distension and pharyngeal receptor mediated lower oesophageal sphincter relaxation.

R K Mittal1, C Chiareli, J Liu, R H Holloway, W Dixon.   

Abstract

BACKGROUND: Atropine decreases the frequency of transient lower oesophageal sphincter relaxation (TLOSR) through an unknown mechanism. Gastric distension and pharyngeal receptor excitation are two possible sources for the afferent stimulus responsible for TLOSR. AIMS: To determine whether atropine affects gastric distension induced TLOSR and pharyngeal receptor mediated lower oesophageal sphincter (LOS) relaxation.
METHODS: Oesophageal manometry and pH recordings were performed in 10 healthy volunteers on two separate days in the postprandial setting, following either atropine (15 micrograms/kg intravenous bolus and 4 micrograms/kg/h as a maintenance dose) or placebo. Pharyngeal receptor mediated LOS relaxation was studied in nine subjects by rapid injection of minute amounts of water (0.05, 0.1, 0.2, 0.3, and 0.4 ml) in the pharynx before and after atropine. Gastric distension mediated TLOSR was studied in eight subjects by insufflating the stomach with 300, 600 and 900 ml of CO2 before and after atropine.
RESULTS: Atropine reduced the frequency of spontaneous gastro-oesophageal reflux and TLOSR compared with placebo (p < 0.05). Pharyngeal stimulation resulted in bolus volume dependent LOS relaxation. Atropine decreased the frequency and amplitude of pharyngeal receptor mediated LOS relaxation at bolus volumes of 0.05, 0.1, and 0.2 ml. Gastric distension resulted in intermittent episodes of TLOSR. The frequency of gastric distension induced TLOSR was significantly decreased by atropine.
CONCLUSION: (1) Atropine reduces the frequency of spontaneous reflux and TLOSR in normal subjects; and (2) gastric distension induced TLOSR and pharyngeal receptor mediated LOS relaxation is inhibited by atropine.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9378379      PMCID: PMC1891504          DOI: 10.1136/gut.41.3.285

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  18 in total

1.  Characteristics of lower esophageal sphincter relaxation induced by pharyngeal stimulation with minute amounts of water.

Authors:  R K Mittal; C Chiareli; J Liu; R Shaker
Journal:  Gastroenterology       Date:  1996-08       Impact factor: 22.682

2.  Experimental induction of isolated lower esophageal sphincter relaxation in anesthetized opossums.

Authors:  W G Paterson; S Rattan; R K Goyal
Journal:  J Clin Invest       Date:  1986-04       Impact factor: 14.808

3.  Response of canine lower esophageal sphincter to gastric distension.

Authors:  S J Franzi; C J Martin; M R Cox; J Dent
Journal:  Am J Physiol       Date:  1990-09

4.  Swallow-evoked action potentials in vagal preganglionic efferents.

Authors:  J S Gidda; R K Goyal
Journal:  J Neurophysiol       Date:  1984-12       Impact factor: 2.714

5.  Swallow-evoked peristalsis in opossum esophagus: role of cholinergic mechanisms.

Authors:  J S Gidda; J P Buyniski
Journal:  Am J Physiol       Date:  1986-12

6.  Abolition of gas reflux and transient lower esophageal sphincter relaxation by vagal blockade in the dog.

Authors:  C J Martin; J Patrikios; J Dent
Journal:  Gastroenterology       Date:  1986-10       Impact factor: 22.682

7.  Importance of vagal input in maintaining gastric tone in the dog.

Authors:  F Azpiroz; J R Malagelada
Journal:  J Physiol       Date:  1987-03       Impact factor: 5.182

8.  Muscarinic activation of rhombencephalic neurones controlling oesophageal peristalsis in the rat.

Authors:  D Bieger
Journal:  Neuropharmacology       Date:  1984-12       Impact factor: 5.250

9.  Mechanisms of gastroesophageal reflux in patients with reflux esophagitis.

Authors:  W J Dodds; J Dent; W J Hogan; J F Helm; R Hauser; G K Patel; M S Egide
Journal:  N Engl J Med       Date:  1982-12-16       Impact factor: 91.245

10.  Characteristics and frequency of transient relaxations of the lower esophageal sphincter in patients with reflux esophagitis.

Authors:  R K Mittal; R W McCallum
Journal:  Gastroenterology       Date:  1988-09       Impact factor: 22.682

View more
  15 in total

Review 1.  Brain meets gut: gastroesophageal reflux.

Authors:  R F Pfeiffer
Journal:  Clin Auton Res       Date:  2001-02       Impact factor: 4.435

2.  Cholinergic blockade inhibits gastro-oesophageal reflux and transient lower oesophageal sphincter relaxation through a central mechanism.

Authors:  J C Fang; I Sarosiek; Y Yamamoto; J Liu; R K Mittal
Journal:  Gut       Date:  1999-05       Impact factor: 23.059

3.  Characterization of the distal esophagus high-pressure zone with manometry, ultrasound and micro-computed tomography.

Authors:  A K Vegesna; J A Sloan; B Singh; S J Phillips; A S Braverman; M F Barbe; M R Ruggieri; L S Miller
Journal:  Neurogastroenterol Motil       Date:  2012-09-24       Impact factor: 3.598

4.  Beyond acid suppression: new pharmacologic approaches for treatment of GERD.

Authors:  Paul Kuo; Richard H Holloway
Journal:  Curr Gastroenterol Rep       Date:  2010-06

5.  Decreased sympathetic inhibition in gastroesophageal reflux disease.

Authors:  S M Campo; A Capria; F Antonucci; G Martino; A Ciamei; P M Rossini; E Bologna; D Cannata
Journal:  Clin Auton Res       Date:  2001-02       Impact factor: 4.435

6.  Effect of L-NMMA on postprandial transient lower esophageal sphincter relaxations in healthy volunteers.

Authors:  D P Hirsch; M M Tiel-Van Buul; G N Tytgat; G E Boeckxstaens
Journal:  Dig Dis Sci       Date:  2000-10       Impact factor: 3.199

7.  Pharmacological dissection of the human gastro-oesophageal segment into three sphincteric components.

Authors:  James G Brasseur; Rhys Ulerich; Qing Dai; Dalipkumar K Patel; Ahmed M S Soliman; Larry S Miller
Journal:  J Physiol       Date:  2007-02-08       Impact factor: 5.182

8.  Effect of atropine on gastro-oesophageal reflux and transient lower oesophageal sphincter relaxations in patients with gastro-oesophageal reflux disease.

Authors:  I Lidums; H Checklin; R K Mittal; R H Holloway
Journal:  Gut       Date:  1998-07       Impact factor: 23.059

Review 9.  Gastroesophageal reflux disease and baclofen: is there a light at the end of the tunnel?

Authors:  James Wise; Jeffrey L Conklin
Journal:  Curr Gastroenterol Rep       Date:  2004-06

Review 10.  Progress with novel pharmacological strategies for gastro-oesophageal reflux disease.

Authors:  Marcello Tonini; Roberto De Giorgio; Fabrizio De Ponti
Journal:  Drugs       Date:  2004       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.